Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2261
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline ; volume:17 ; number:1 ; day:16 ; month:8 ; year:2017 ; pages:1-7 ; date:12.2017
BMC cardiovascular disorders ; 17, Heft 1 (16.8.2017), 1-7, 12.2017

Schlagwort
Kardiovaskuläre Krankheit

Urheber
Journath, Gunilla
Beteiligte Personen und Organisationen
Hambraeus, Kristina
Hagström, Emil
Pettersson, Billie
Löthgren, Mickael
SpringerLink (Online service)

DOI
10.1186/s12872-017-0659-2
URN
urn:nbn:de:1111-201710301718
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:31 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Journath, Gunilla
  • Hambraeus, Kristina
  • Hagström, Emil
  • Pettersson, Billie
  • Löthgren, Mickael
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Cardiovascular magnetic resonance in carotid atherosclerotic disease

Cardiovascular magnetic resonance in carotid atherosclerotic disease

The gut microbiome in atherosclerotic cardiovascular disease

The gut microbiome in atherosclerotic cardiovascular disease

Spatial analysis of 10-year predicted risk and incident atherosclerotic cardiovascular disease: the CoLaus cohort

Spatial analysis of 10-year predicted risk and incident atherosclerotic cardiovascular disease: the CoLaus cohort

Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses

Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention

Cardiovascular outcome trials of glucose-lowering medications: an update

Cardiovascular outcome trials of glucose-lowering medications: an update

Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases

Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases

The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy

The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy

Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease

Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease

Machine learning reveals sex-specific associations between cardiovascular risk factors and incident atherosclerotic cardiovascular disease

Machine learning reveals sex-specific associations between cardiovascular risk factors and incident atherosclerotic cardiovascular disease

Sex-Specific Association Between Iron Status and the Predicted 10-Year Risk for Atherosclerotic Cardiovascular Disease in Hypertensive Patients

Sex-Specific Association Between Iron Status and the Predicted 10-Year Risk for Atherosclerotic Cardiovascular Disease in Hypertensive Patients

Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)

Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)

Verbundene Objekte